Dr. Sarina Piha-Paul, MD
Claim this profileMD Anderson Cancer Center
Expert in Solid Tumors
Expert in Tumors
34 reported clinical trials
51 drugs studied
Area of expertise
1Solid Tumors
Global LeaderStage IV
BRAF positive
Stage III
2Tumors
Global LeaderStage IV
BRAF positive
Stage III
Affiliated Hospitals
Clinical Trials Sarina Piha-Paul, MD is currently running
ABM-168
for Advanced Solid Tumors
This is a Phase 1, First-in-Human (FIH), open-label, multicenter, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of ABM-168 in adult patients with RAS or RAF or NF-1 mutated advanced solid tumors as ABM-168 may have a significant effect in inhibiting cell growth.
Recruiting1 award Phase 1
SHR-A1904
for Advanced Cancer
This trial is testing a new drug called SHR-A1904 to see if it is safe and effective for people with advanced solid tumors. The study will determine the best dose to use and check how the drug moves through the body. Researchers also want to know if the drug helps fight cancer without causing harmful side effects.
Recruiting1 award Phase 1 & 2
More about Sarina Piha-Paul, MD
Clinical Trial Related6 years of experience running clinical trials · Led 34 trials as a Principal Investigator · 17 Active Clinical TrialsTreatments Sarina Piha-Paul, MD has experience with
- Pembrolizumab
- AMXT1501
- DFMO
- Nivolumab
- Neratinib
- Palbociclib
Breakdown of trials Sarina Piha-Paul, MD has run
Solid Tumors
Tumors
Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sarina Piha-Paul, MD specialize in?
Sarina Piha-Paul, MD focuses on Solid Tumors and Tumors. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are BRAF positive.
Is Sarina Piha-Paul, MD currently recruiting for clinical trials?
Yes, Sarina Piha-Paul, MD is currently recruiting for 17 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Sarina Piha-Paul, MD has studied deeply?
Yes, Sarina Piha-Paul, MD has studied treatments such as Pembrolizumab, AMXT1501, DFMO.
What is the best way to schedule an appointment with Sarina Piha-Paul, MD?
Apply for one of the trials that Sarina Piha-Paul, MD is conducting.
What is the office address of Sarina Piha-Paul, MD?
The office of Sarina Piha-Paul, MD is located at: MD Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the MD Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.